Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy
Article in Journal of Medicinal Chemistry (April 2024)
The most recent citing publications are shown below. View all 240 publications that cite this research output on Dimensions.
Article in Journal of Medicinal Chemistry (April 2024)
Article in Journal of Medicinal Chemistry (April 2024)
Article in Aging and Disease (April 2024)